Equillium, Inc.

Equillium, Inc. (NASDAQ: EQ) is a biotechnology company associated with clinical trials that create and market medications to treat extremely severe autoimmune and inflammatory, or immuno-inflammatory, illnesses.  As per the previous report on EQ as on July 14, 2022, a ‘Speculative Buy’ recommendation was given on the stock at USD 2.23, and noted below are the details of the Support / Resistance summary provided in the previous report:

Support / Resistance Summary as on July 14, 2022

EQ’s Daily Chart

Considering the resistance levels achievement, current trading levels and risks associated, it is prudent to book profits at the current levels. Hence, a ‘Sell’ rating has been provided on the stock at the close price of USD 3.14 as of August 17, 2022.

Note 1: Past performance is not a reliable indicator of future performance.

Note 2: The reference date for all price data, currency, technical indicators, support, and resistance levels is August 17, 2022. The reference data in this report has been partly sourced from REFINITIV.

Note 3: Investment decisions should be made depending on an individual's appetite for upside potential, risks, holding duration, and any previous holdings. An 'Exit' from the stock can be considered if the Target Price mentioned as per the Valuation and or the technical levels provided has been achieved and is subject to the factors discussed above.

Technical Indicators Defined: -

Support: A level at which the stock prices tend to find support if they are falling, and a downtrend may take a pause backed by demand or buying interest. Support 1 refers to the nearby support level for the stock and if the price breaches the level, then Support 2 may act as the crucial support level for the stock.

Resistance: A level at which the stock prices tend to find resistance when they are rising, and an uptrend may take a pause due to profit booking or selling interest. Resistance 1 refers to the nearby resistance level for the stock and if the price surpasses the level, then Resistance 2 may act as the crucial resistance level for the stock. 

Stop-loss: In general, it is a level to protect further losses in case of any unfavourable movement in the stock prices.